Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Testing Trends: AMP Creates New Quality Guidelines for PGx Laboratory Testing
...
Already a member? Log in here
Test Utilization: New Guidelines Recommend Basing Routine Colorectal Cancer Screening on Risk Rather than Age
...
Already a member? Log in here
Innovation: Breathalyzer May Offer Reliable, Easier Alternative to Blood-Based Opioid Detection
...
Already a member? Log in here
Inside the Diagnostics Industry: Quest-hc 1 System Leverages Lab Data to Help Providers Monitor Test Utilization
...
Already a member? Log in here
New Study Suggests Blood Testing May Be Capable of Diagnosing PTSD
...
Already a member? Log in here
Laboratory Information Systems (LIS): What You Need To Know To Get Paid
By Sean McSweeney bio
Today, laboratory billing claims require more and more data to successfully get paid.
One of the biggest reasons your claims may be getting denied is because…
Inside the Diagnostics Industry: New Government BRCA Test Guidelines Are a Mixed Bag for Genetic Testing Labs
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…
Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
...
Already a member? Log in here